IRIS
GREMESE, ELISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 557
AS - Asia 471
EU - Europa 219
AF - Africa 8
SA - Sud America 7
OC - Oceania 1
Totale 1.263
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 546
SG - Singapore 404
CN - Cina 51
FI - Finlandia 40
CZ - Repubblica Ceca 36
IE - Irlanda 31
DE - Germania 29
IT - Italia 21
FR - Francia 13
GB - Regno Unito 11
BE - Belgio 10
CA - Canada 10
RU - Federazione Russa 8
NG - Nigeria 7
IN - India 5
LT - Lituania 5
NL - Olanda 5
SE - Svezia 5
AT - Austria 4
CL - Cile 4
PK - Pakistan 3
BR - Brasile 2
GE - Georgia 2
IL - Israele 2
AM - Armenia 1
AR - Argentina 1
AU - Australia 1
EG - Egitto 1
JP - Giappone 1
KR - Corea 1
PA - Panama 1
RO - Romania 1
TH - Thailandia 1
Totale 1.263
Salva come PNG Salva come JPEG
Città #
Singapore 279
Chandler 117
Boardman 70
Shanghai 44
Helsinki 39
Dublin 31
Wilmington 28
Ashburn 27
Brno 24
Santa Clara 22
New York 20
Lawrence 13
Munich 13
Princeton 13
Olomouc 12
Paris 12
London 11
Brussels 10
San Mateo 10
Benin City 7
Toronto 7
Ann Arbor 5
Collegeville 5
Frankfurt am Main 5
Leawood 5
Los Angeles 5
Scandicci 5
Woodbridge 5
Amsterdam 4
Moscow 4
Pune 4
Redwood City 4
Sassari 4
Lahore 3
Ottawa 3
Phoenix 3
Seattle 3
Tukwila 3
Beijing 2
Campinas 2
Fairfield 2
Falkenstein 2
Gorle 2
Milan 2
Pavia 2
Shenzhen 2
Vienna 2
Bangkok 1
Bologna 1
Bothell 1
Buffalo 1
Cairo 1
Cambridge 1
Clifton 1
Council Bluffs 1
Florence 1
Forest City 1
Hangzhou 1
Las Vegas 1
Monmouth Junction 1
Nanjing 1
Nuremberg 1
Panama City 1
Río Cuarto 1
Santiago 1
Sydney 1
Tel Aviv 1
Tokyo 1
Yerevan 1
Totale 919
Salva come PNG Salva come JPEG
Nome #
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 47
Systemic sclerosis myocarditis has unique clinical, histological and prognostic features: a comparative histological analysis. 47
A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naive patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial 45
Anti-LL37 Antibodies Are Present in Psoriatic Arthritis (PsA) Patients: New Biomarkers in PsA. 44
Achievement of sustained deep remission with adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis 36
Real-life effectiveness of ustekinumab in inflammatory bowel disease patients with concomitant psoriasis or psoriatic arthritis: An IG-IBD study 36
Real-life effectiveness of ustekinumab in inflammatory bowel disease patients with concomitant psoriasis or psoriatic arthritis: an IG-IBD study 31
Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis 30
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease 29
Safety and efficacy of rituximab biosimilar (CT-P10) in systemic sclerosis: an Italian multicentre study 27
B cell depletion and a T cell-targeted therapy allows to control the sudden onset of diabetes and lupus, without steroids 27
Synovial B cells of rheumatoid arthritis express ZAP-70 which increases the survival and correlates with the inflammatory and autoimmune phenotype 24
Severe eosinophilic asthma and aspirin-exacerbated respiratory disease associated to eosinophilic gastroenteritis treated with mepolizumab: a case report 23
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients 20
Therapeutic Drug Monitoring is More Cost-Effective than a Clinically Based Approach in the Management of Loss of Response to Infliximab in Inflammatory Bowel Disease: An Observational Multicentre Study 19
IL-1B and IL-1RN gene polymorphisms in rheumatoid arthritis: relationship with protein plasma levels and response to therapy 19
Effectiveness of IL-12/23 inhibition (ustekinumab) versus tumour necrosis factor inhibition in psoriatic arthritis: observational PsABio study results 19
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real???Life Setting 15
Spondiloartriti sieronegative 11
Gastrointestinal involvement in systemic vasculitis 10
Metabolic syndrome in autoimmune diseases: prevalence and relationship with the inflammatory burden 10
Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis 10
Artrite Reumatoide 10
The Role of Microrna-34 and Microrna-22 in Dendritic Cells and Monocyte Activation in Rheumatoid Arthritis 10
Measuring the T-cell down-regulation of TCR-zeta, ZAP-70 and CD28 in arthritis patients: An old tool for new biomarkers 10
Circulating Human Collagen II-Reactive T Cell in Early Rheumatoid Arthritis Produce IL17. 9
Off-label use of rituximab for SLE in Europe: a comparison to patients treated with conventional immunosuppressive medications 9
EFFECTIVENESS AND SAFETY OF BELIMUMAB IN PATIENTSWITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM A LARGE, NATIONWIDE, MULTICENTRIC STUDY 9
CD19+ cells subsets (CD5, CD38 and CD23) in peripheral blood and synovial fluid of rheumatoid arthritis patients: relationship with disease activity and with auto-antibody levels 9
Metaflammation, PEDF and Chemerin: Potential Systemic Factors Which Link Obesity To Response To Therapy In Early Rheumatoid Arthritis. 9
Biological therapies in autoimmune chronic inflammatory diseases (ACIDs) 9
Artrite reumatoide 8
Porphyromonas Gingivalis and the Pathogenesis of Rheumatoid Arthritis: Analysis of the Synovial Tissue and of Other Compartments 8
Is Citrullination Required for the Presence of Restricted Clonotypes Reacting With Type II Collagen? Comment on the Article by Chemin et al 8
Lupus eritematoso sistemico 8
Adult onset Still's disease and pregnancy 8
[Class IV-G and IV-S lupus nephritis, interstitial infiltrates and prognosis: state of the art and unmet medical needs] 8
Rheumatologic Symptoms in Patients with Mixed Cryoglobulinemia 8
Depression and Endothelial Dysfunction in Psoriatic Arthritis: Is There Any Possible Relationship? 8
Access of arthritis patients to an early arthritis clinic in three different settings: the very early ra represents the best clinical and therapeutic opportunity to reach das remission. Quality indicators (QI) of the italian ministry of health program 8
B-cell directed therapy in rheumatoid arthritis: predictive factors of efficacy and assessment of regeneration profile 8
The body mass index: a determinant of remission in early rheumatoid arthritis 8
Comment on: Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease 8
Biologics use in SLE in 23 centers – data from the international registry for biologics in SLE 7
The prognostic significance of the Birmingham Vasculitis Activity Score (BVAS) with systemic vasculitis patients transferred to the intensive care unit (ICU) 7
Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases) 7
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study-Joint and Skin (BeRLiSS-JS) 7
An unusual lung involvement in scleroderma: lipoid pneumonia 7
ZAP70 B Cells and Plasmablasts As Markers of Disease Activity and Remission in Systemic LUPUS Erythematosus Nephritis 7
Very early rheumatoid arthritis is the major predictor of major outcome: clinical ACR remission and radiographic non-progression 7
A brief battery for the evaluation of cognitive deficits in italian SLE patients 7
ACPA–IL-6 as the best biomarkers to differentiate early rheumatoid arthritis from undifferentiated arthritis: analysis of the diagnostic performance 7
Paradoxical arthritis occurring during anti-TNF in patients with inflammatory bowel disease: histological and immunological features of a complex synovitis 7
Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis 7
Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease 6
Analysis of response to infliximab in ankylosing spondylitis (AS) according to the axial and/or peripheral involvement. autoantibodies and drop outs are more frequent in the peripheral subset 6
Persistence, effectiveness and safety of ustekinumab compared to TNF inhibitors in psoriatic arthritis within the Italian PsABio cohort 6
An autosomal recessive DNASE1L3-related autoimmune disease with unusual clinical presentation mimicking systemic lupus erythematosus 6
Early rheumatoid arthritis (ERA) differs from long-standing RA (LSRA) in circulating B cell subsets. changes according to disease activity under conventional therapy 6
Results of the classification criteria for cryoglobulinemic vasculitis validation study 6
Antineutrophil cytoplasmic autoantibodies (ANCA) positivity as a red flag of severe disease in lupus nephritis 6
Renal inflammatory infiltrate in lupus nephritis patients 6
Definition of fibromyalgia severity: Findings from a cross-sectional survey of 2339 Italian patients 6
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 6
Adiposity, joint and systemic inflammation: the additional risk of having a metabolic syndrome in rheumatoid arthritis 6
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 6
Analysis of improvements, full responses, remission and toxicity in rheumatoid patients treated with step-up combination therapy (methotrexate, cyclosporin A, sulphasalazine) or monotherapy for three years 6
Metabolic syndrome, QTC interval lengthening and inflammation in rheumatoid arthritis. Analysis of their respective role 6
Adult Onset Still's Disease and Radiotherapy treatment for breast cancer: Case report about management of this rare association and literature review 6
Early Spondyloarthritis Clinic: Organizational Improvements in the Patient Journey 6
Long-term anti-TNF therapy and risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison among adalimumab, etanercept and infliximab 6
Gene-gene interaction and early rheumatoid arthritis: effects on the response to therapy 5
Tocilizumab in the treatment of arthritis: response to therapy and evaluation of B cells subsets after 4 months treatment 5
A multiparametric risk table for loss of clinical remission status in patients with rheumatoid arthritis: A starter study post-hoc analysis 5
The B side of rheumatoid arthritis pathogenesis 5
The role of High-mobility group box protein 1 in collagen antibody-induced arthritis is dependent on Vascular endothelial growth factor 5
Peripheral blood B cells subsets in patients with systemic lupus erythematosus: correlation with disease activity and organ involvement 5
Predictors, Features and Effects of First Biologic Switch in Rheumatoid Arthritis within GISEA register: Italian 10-Year Experience. 5
B cell activating factor (BAFF) and BAFF receptors: fakes and facts 5
Statins and mortality in connective tissue diseases: Should we resume the cardio-rheumatology spirit in our clinics? 5
ACR70-disease activity score remission achievement from switches between all the available biological agents in rheumatoid arthritis: a systematic review of the literature 5
Association of the 22 genotype of enhancer HS1,2A of the Ig heavy 3′ regulatory region with non response to DMARDS and response to rituximab in rheumatoid arthritis patients 5
A brief battery for the evaluation of cognitive deficits in italian SLE patients 5
Early Rheumatoid Arthritis (ERA) Has Lower Levels of Plasmablasts and Memory B Cells Compared to Long-Standing Rheumatoid Arthritis (LSRA) and Responds to Conventional Therapy with a Normalization of B Cell Subsets Abnormalities. 5
Abatacept in the treatment of psoriatic arthritis: biological and clinical profiles (of the responders) 5
Anti-nucleosome antibodies: correlations with activity and chronicity disease indexes in systemic lupus erythematosus patients with renal involvement 5
Loss of α2-6 sialylation promotes the transformation of synovial fibroblasts into a pro-inflammatory phenotype in arthritis 5
Circulating memory B cells characterize active nephritis instead activated naïve B cells are expanded in active articular involvement in patients with systemic lupus erythematosus (SLE) 5
B-cell depletion in rheumatoid arthritis: searching for serologic and clinical baseline factors that could predict long-term efficacy 5
Anti-nucleosome antibodies: correlations with activity and chronicity disease indexes in systemic lupus erythematosus patients with renal involvement 5
Predictive Factors for a New Positive Nasopharyngeal Swab Among Patients Recovered From COVID-19 4
Integrin alpha2bbeta3 gene polymorphism and the microvascular system in scleroderma 4
The UltraSound-CLinical ARthritis Activity (US-CLARA) index: Properties of a new composite disease activity index for rheumatoid arthritis 4
Minimal disease activity in early and longstanding rheumatoid arthritis 4
Basophil activation and serum IL-5 levels as possible monitor biomarkers in severe eosinophilic asthma patients treated with anti-IL-5 drugs 4
Relationship between the tumor necrosis factor receptor II (TNF-RII) gene polymorphism and sTNF-RII plasma levels in healthy controls and in rheumatoid arthritis 4
Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response 4
High risk of misclassification of acute Parvovirus B19 infection into a systemic rheumatic disease 4
Free light chains of immunoglobulins in patients with systemic sclerosis: correlations with lung involvement and inflammatory milieu 4
Smoking and inflammation independently affect anti-CCP levels in early RA 4
Totale 1.073
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.193
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.193
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 0 0 0 0 0 0 0 0 0 0 0 2
2020/202159 0 0 0 0 1 26 7 2 11 8 0 4
2021/202229 1 0 1 6 0 1 1 3 3 5 4 4
2022/2023277 28 13 28 43 21 25 0 27 45 30 16 1
2023/2024728 11 13 54 15 1 32 18 9 5 7 19 544
2024/2025457 181 27 136 64 49 0 0 0 0 0 0 0
Totale 1.552